Showing posts with label Fitness. Show all posts
Showing posts with label Fitness. Show all posts

Monday, July 6, 2009

ARTICLE XXII - Balloons and Heart

0 comments
The entry of balloons has heralded a new era in the world of medicine with profound effects in its various important fields. The strongest ripples were however felt in cardiology and specialties dealing with gastroenterology, anaesthesia and urinary system. In cardiology it has revolutionized the approach to many commonly encountered problems. Many more fields await the application of this exciting ‘balloon technology’!

What can balloon do for us? It has been used to track into blood carrying tube – vessels, as air is lighter than blood, so this travels along the course of the vessels. It has been used for retention of a tube in a cavity, with balloon inflated on an end of tube after the entry has been secured prevents its slippage. Similarly it has been used to retain the urinary catheter in the bladder by inflating the balloon at the end. Tubes used in anaesthesia used to have leaking of air around it, that problem is solved by inflating balloon around it. Balloons have been used to arrest bleeding in patients with bleeding varices in dire emergency by exerting direct pressure on bleeding varices.

The biggest breakthrough came with the realization that these balloon could be employed to ‘blow up’ blockages in various parts of body. Balloons of different sizes and quality mounted on different structures have been successfully used for this purpose. They have been used to open up obstructions in gastrointestinal tract without surgery. Blockages in urinary system have been dilated by balloons with minimal patient discomfort and without surgery.

The epic of balloon technology can be witnessed in cardiology where the whole scenario has changed in cardiac catheterization laboratory. Initially cardiac catheterization laboratory was used truly as a laboratory where different diseases were diagnosed based on the information gleaned from catheterization. Now the emphasis is shifting from diagnosis to therapeutics. With the advent of echocardiography, most diseases can be accurately diagnosed without cardiac catheterization. In cardiac cath lab, catheter based therapeutics is predominantly dependent on “poor old balloon”, small balloons blowing up obstruction in coronary and other vessels with excellent results and large balloons opening up narrowed valves with enviable results obviating the need for surgery.

Valvuloplasty:
Large balloons ranging from 10 to 30 mm in diameter are used to open up different valves. Obviously, size of balloon depends on the target and size of patient. These valves are either congenitally narrow or narrow down in later life due to various disease process. Previously surgery was required to open up the stenosed valves and remove the impediments in blood flow. Not any more! The procedure is performed without anaesthesia. As an initial step baseline data is recorded, then access beyond the narrowed valve is secured by manipulating a flexible catheter across it. A long wire is left across the valve and a narrow balloon mounted catheter is manipulated on the wire across the narrowed valve. Once satisfied with the position, the balloon is inflated, first a waist appears confirming the impinging valve on balloon and then it slowly gives way. The The valve is open! No ugly scar on chest, no confinement to bed for days, no need for prolonged antibiotics, no loss of work and the beauty is that the patient can actually walk home the next day.

Obviously these balloon mounted catheters are made of very sophisticated material and a lot of research has been done to perfect the technique and hardware. The catheter system to open Mitral valve is named after Inoue. The only way to cut down the costs are to reuse the balloon after proper sterilization. The chances of success are more than ninety five percent and complication rate is quite low. The balloon used for Pulmonic and Aortic valves are different in size and shape.

Angioplasty (PCI)
Balloon have only recently been tamed, to be used in small vessels supplying heart. It started with Andrea Grundzick in 1979, when a blockage in a vessel was opened in a patient. Since then there has been an explosion in the cath lab of angioplasties. In USA, it is called ‘occulo dilating reflex’ which implies that as soon as a cardiologist sees an obstruction in a vessel, he has an irrepressible urge to dilate it. Or, according to our not very good friends, cardiologists on seeing a blockage develop severe stomach ache which can only be relived on opening up that lesion. No doubt there has been a mad race in opening of the lesions and technology is witnessing tremendous progress in this field.

Most research taking place in cardiology is focused on small balloons used in vessels supplying heart. The aim is to produce tough balloons which can endure high pressure without deforming, mounted on catheter which should have very small profile so that it can negotiate the bends and cross the blockage, the catheters should have enough strength to be pushed around and cross the lesion. Similar research is taking place in paraphernalia like catheter and guide wire.

How is it done? After identifying the blockage a strategy is devised regarding the approach and hardware to be employed. The procedure is similar to angiography where no anaesthesia is administered. After doing angiography, the lesion is crossed with the help of a very find guide wire. Care is taken to float this wire across the lesion preventing it from going to small branches. It is like going through a large tree to a specific branch which might take a minute or a couple of hours. Once the lesion is crossed balloon mounted catheter is introduced and parked at the lesion. The size of balloon chosen depends on the size of the vessel. Satisfied with the position of catheter, the balloon is inflated under X-ray control. Patient experiences pain when balloon is inflated as blood supply to a part of heart is totally prevented. The balloon is kept inflated for as long as a patient can tolerate, varying from a few seconds to a minute. The appearance of waist and later giving way is apparent on X-ray. The lesion gives way with increase in lumen size.

Balloon are also being used to dilate obstructions in vessels supplying brain, kidneys and extremities. New territories are being ventured into and with the development of proper hardware the need for surgery will be obviated in most cases.

Introduction of balloon technology is a fine example of application of common sense to common problems. Balloons have been used for retention, and opening up blockages. This has proven to be a major advance in medicine and surgery and almost all specialties are benefiting from this simple but very exciting technology.

___________________________________________________
Ref: Heal Thy Heart written by Prof: Dr. Muhammad Hafizullah

Read more...

ARTICLE XXI - Heart Transplant - Is it a Viable Option?

0 comments
“Heart transplants have been successfully performed since 1967. Latest figures tell us that 85 percent of those who receive heart transplants survive for more than one year, and 70 percent live five years following the procedure,” I told John Plant, a 40 years old bank with a dilated and poorly pumping heart. He had been in and out of the hospital many times in the last six months. He was on maximal treatment but his effort tolerance remained severely impaired. We had proposed ‘heart transplant’ to him and his first knee jerk reaction was a big ‘no’. “A dream has been transformed into a reality and many patients are enjoying nearly normal life after heart transplant. Today’s heart transplant recipients live longer after surgery than those who received heart transplants just 10 years ago. Many transplant patients go back to work and many participate in moderately strenuous activities, such as walking, swimming and even running,” I added to convince him and eventually he agreed to go for it. Two years down the lane, he was active, playing golf and enjoying holidays in Paris.

Heart transplant has emerged as an established safe and effective theraphy for patients with severe heart problems. Technique of heart transplantation has made great strides of development over the years. Indeed it is a major surgery, in which a severely diseased or damaged heart is replaced with a healthy heart from a recently deceased person. Mortality during surgery is acceptable and the biggest problems are find a heart and prevention of rejection. Patients continue to face a lengthy waiting list to receive a donor heart. According to the recent figures approximately 3,800 patients were waiting for a heart transplant as of June 2007. Only 2,148 people received a donated heart in 2007. According to the American Heart Association, at the present time all over the world, the majority of heart transplant patients were while males. More than half are between the ages of 50 and 64, and about 20 percent are between the ages of 35 and 49. Researches are working to develop equipment to improve the health and comfort for patients waiting for a donor heart and, ideally, to develop a mechanical heart that could permanently solve the shortage problem.

Who needs heart transplant?
When a patient is diagnosed as having an end-stage heart disease, and all medical interventions have failed, and the patient is stable enough to sustain a major surgery then he or she is considered for transplant. End stage heart disease due to decrease in blood supply – coronary artery disease and disease of heart muscle called cardiomyopathy are the most common conditions that may lead to a heart transplant. Heart diseases due to inborn heart problems which are not amenable to surgery are the most common reasons for heart transplant in children. Patients with failure of a previous bypass and persistent angina and heart failure are considered for heart transplant.

Heart transplants are sometimes performed along with lung transplants for individuals with end-stage lung disease that also involves the heart. These conditions are elevated pressures in right sided circulation called pulmonary hypertension. High blood pressure in blood vessels of lungs arising from right side of heart is consequent to either primary – where the cause is not known or Eisenmenger syndrome where the cause is a congenital heart disease. The condition accounts for nearly half of all heart-lung transplants.

Who donates the heart?
Unlike most organs, the heart can only be obtained from donors who die a “brain death,” meaning that the brain dies while the body remains on life support. Organs are obtained from people who give their consent to have certain organs donated. They can also be obtained by permission of next of kin when a suitable donor is considered to be “brain dead.” Although almost 40 percent of donated kidneys are surgically removed from living donors, most major organ donations (e.g., the heart, lungs and liver) are pledged while living and removed when the donor dies. Because of the great demand for organ donors, generally healthy people are strongly encouraged to become donors.

How the heart is transplanted?
Patients waiting for a donor heart are required to report to the hospital immediately on finding a donor. If the donor heart is in the same hospital as the recipient, then the surgery is performed as soon as all preparations have been made. If the donor heart is being transported by ambulance or by air, then the surgical team responsible for the transfer keeps the hospital team informed of their progress.
When the time is right, the patient is given general anesthesia. An incision is made through the chest and sternum, and the ribs are separated. A heart-lung machine takes over the functions of heart and lungs, freeing heart from its normal function so that it can be removed. Some heart muscle is reserved during extraction to act as a support for the new heart as it is sewn into place. When the new heart is positioned and blood vessels are reattached, a heart incision is closed, heart is restarted and blood circulation and oxygen are stored. The warmth of blood should “wake up” the heart and stimulate it to start beating. If this does not occur, it may be necessary to start the heart using an electric shock (defibrillation). Once blood is flowing through the new heart normally and without any leaks, the heart-lung machine is disconnected and chest incision is closed.

After the heart transplant, patient is kept in ICU and monitored during this critical time by cardiac surgeon, cardiologist and other members of the hospital staff. They watch closely for any signs of heart rejection or infection. Medications that suppress the body’s natural immune system are administered to counter the body’s tendency to reject the new heart, and these medications have dramatically reduced the number of rejections.

Patients are unlikely to be very active in the next couple of days, but should be able to walk around in just three or four days. The total length of a hospital stay after a heart transplant is 10 to 14 days. Once a patient is discharged from the hospital, cardiologist and primary physician provide regular medical support, including biopsies and other diagnostic tests several times a year.

The improved life expectancy of patients after a heart transplant is largely due to a new drug called cyclosporine. It is an immunosuppressive drug that appeared in 1983. From its unique way of suppressing the immune system, cyclosporine has become a mainstay in minimizing the body’s tendency to reject a new heart. This is a major risk associated with transplant surgery. When rejection occurs, the immune system sends out antibodies to destroy the new heart, which is perceived as foreign or ‘invading’ tissue cells. Left unchecked, this rejection can result in extensive damage and failure of the transplanted heart.

Problems after the transplant:
Three main problems associated with transplant are rejection, infection and accelerated atherosclerosis.

a. Rejection: Certain tests are required on a regular basis to predict whether the heart is being rejected. These tests include regular biopsies and serial blood tests. Serial biopsies are done to monitor body’s response to the transplanted heart. This involves using a thin tube to remove a small piece of heart tissue. The tube is inserted through a vein either in the groin or side of the neck. Biopsies are outpatient procedures that can be done in under an hour. They are performed often in the first four months after transplantation and, less frequently, in months and years after that. The risk of transplant failure is three times greater among recipients with high levels of troponin I than those with normal levels of this enzyme.
Patients can monitor themselves, as some symptoms may signal rejection, including dizziness, nausea or vomiting, chest pain, shortness of breath, flu-like symptoms like chills, sore throat and fever. Rejection, however, is not necessarily an irreversible event. It can be controlled with different dosage regimen or timing of medications. Patients are encouraged to immediately contact their transplant centre or team, should any of the above symptoms occur.

b. Infection. Patients are urged to immediately report to their physician if any of the following signs of infection like fever, redness, swelling and drainage of fluid appear.

c. Accelerated atherosclerosis. When patients receive a new heart, they also receive new coronary arteries on the surface of that heart. Although these new coronary arteries may have less blockages than their original coronary arteries, heart transplant recipients are more like to develop coronary artery disease (CAD). This disease is thought to be part of the slow rejection process in the transplanted hearts. About 50 percent of heart transplant patients develop CAD. Therefore, patients must undergo cardiac tests periodically to check for the disease.

A longer-term goal for some researchers is the genetically engineered heart. The organ is composed of human tissues – perhaps one’s own – and is cultured or grown over a period of months to match detailed specifications. Currently, this “heart-in-a-box” project exists only in a university research facility, but researchers have a goal to have cryogenically (defined as ‘low-temperature”; in this case, very cold) stored organs available for transplant in less than a decade.

The dreams of yesterday have worn the attire of reality today. Heart transplant is a viable option in selected patients with heart failure, who do not respond to maximal therapy. Due to recent technological advances, the outlook has improved, survival being more than 83% at one year.

___________________________________________________
Ref: Heal Thy Heart written by Prof: Dr. Muhammad Hafizullah

Read more...

ARTICLE XX - Bypass Surgery - Anything new?

0 comments
Farhan, a thirty five year old banker, underwent bypass surgery three years ago. He is back to work, working full time and enjoying his game of golf every evening. He flies abroad to attend meetings and makes full contribution to his job. He is only taking a couple of tablets and observes a few restrictions in his diet. For all practical purposes, he is leading a very active and productive life. And so are most people at different ages, employed in different jobs, from both sexes who had bypass surgery!

Bypass surgery is the most commonly performed heart surgery for coronary artery disease. Persons who develop blockages in their tubes that supply the heart called coronary arteries are the candidates for such surgery. More than 300,000 people have successful by pass surgery only in the United States each year. Bypass surgery is now being routinely performed in major centres of Pakistan with acceptable morbidity and mortality.

What is bypass operation?
Arteries supplying heart, called coronary arteries, develop blockages and can become clogged. Bypass surgery improves blood flow to heart employing a new route, or by “bypassing” blockages in the clogged or diseased artery. The surgery involves using a part of vein from leg or an artery from chest or another part of body to bypass the blocked part of the diseased coronary artery. This creates a new route for blood to flow, so that the heart muscle gets uninterrupted oxygen-rich blood.

How is bypass operation performed?
During bypass surgery, the breast bone (sternum) is divided, heart is stopped, and blood is circulated through a heart-lung machine which performs the function of heart and lungs. Unlike other forms of heart surgery, the chambers of heart are not opened during the operation. Heartlung machine takes over circulation and given enough time to operation on a stand still heart which makes surgery like this possible. The use of machine allows the surgeon to stop heart while the vital organs continue to receive blood and oxygen. Meticulous surgery can be done without interference from bleeding or heart’s pumping motion. Used successfully for the first time in 1953, the machine has proved to be a revolutionary piece of equipment. A perfusion technologist operates the machine. Before hooking upto this machine, a blood-thinning medicine called an anticoagulant is given to prevent blood from clotting. Two large sized cannulas are put in and sewn in major vessels which carry the blood back from inferior and superior vena cava. This blood is oxygenated by the machine like lungs as blood passes in close vicinity of controlled oxygen. A mortorized system then drives this blood back to body where it is delivered to aorta through a cannula to be further distributed to all over body. Meticulous control of speed of motors is required, drawing blood out of body and then delivering back. The amount of oxygen and anticoagulation has to be managed carefully.

The surgical team is led by a cardiovascular surgeon and includes other assisting surgeons, an anesthesiologist, and surgical nurses. A long piece of vein from leg (the saphenous vein) is removed. This piece of vein is called a graft. One end of the graft is attached to ascending aorta, the large artery that carries oxygen-rich blood out of the heart to the body. Other end of the graft is attached to coronary artery below the blockage. The surgeon may choose to use an artery from the inside of chest wall (the internal mammary artery) instead. Or the surgeon may use both vein and artery. The procedure can take from 1 to 2 hours, depending on the number of bypasses needed. The stay in the hospital is about a week, including at least 1 to 3 days in the Intensive Care Unit (ICE). It may prolong in case of any complications. Usually the patient is up and about after two to three days and is encouraged to walk liberally after that.

Advances in bypass surgery:
There have been continuous attempts to make bypass surgery lesser invasive and more patient friendly. Minimally invasive coronary artery bypass surgery has been a major advance. It is done through smaller incisions. It may involve using the mammary artery as a graft. Saphenous veins may also be used. The procedure may be done without stopping heart. Some patients can leave the hospital within 48 hours. This operation is only used for patients whose blockages can be bypassed through this smaller incision and whose risk of complications is low.

Off pump surgery has been heralded as a major step forward to improve post operative course and complications besides reducing the cost. Like conventional bypass surgery, off-pump coronary artery bypass surgery (OPCAB) bypasses blockages in coronary arteries. Off-pump bypass involves the same two procedures that are performed during traditional bypass surgery. In the first, the surgeon removes (harvests) one of the patient’s blood vessels – usually either saphenous vein in leg or mammary artery. In the second procedure, the surgeon uses the blood vessel to create a detour (bypass graft) around the blockages in coronary arteries.

Off-pump bypass allows the surgeon to sew the bypass grafts into place in the chest without stopping heart. This eliminates all risks associated with stopping heart that is necessary during traditional bypass surgery. It also reduces the risk that a patient may experience depression and/or mood swings following surgery – a common side effect with traditional bypass surgery. The surgeon uses certain heart stabilizers and positioners to keep the targeted region of heart virtually motionless while working on a particular coronary artery. The stabilizers restrict heart’s motion to create a stable and nearly still work area for the surgeon. Heart maintains its own rhythm throughout the procedure. In addition, bleeding is greatly reduced, so patients are less likely to need blood transfusion.

What does life promise after bypass?
A person can go back to normal life and job in four to six weeks following an uncomplicated surgery. It may take longer in older age group, those with poor heart function and those with coexistent serious medical problems. One can usually go back to work in 4 to 6 weeks for an office job. Those who have more physically demanding jobs may need to wait longer. In some extreme cases, one may need to find a job that is not as physically demanding. Twenty percent or less of bypass patients may need a second procedure like angioplasty or repeat bypass after 10 years.

Does bypass mean an end to walking and abstinence from cholesterol rich diet?
Is bypass surgery a panacea? Does it give a license to eat and drink as one pleases? Two things are of vital importance after bypass operation: first, meticulous control of risk factors and second, regular exercise. After bypass surgery, the diet has to be modified and one has to limit fat and cholesterol. Risk factors have to be regularly watched and scrupulously controlled. Exercises like walking and swimming are recommended, to get the strength back and develop stamina. The role of exercise has been discussed in details in controlling various risk factors. A cardiac rehabilitation program may be joined on doctor’s recommendation. These programs can help to make lifestyle changes like starting a new diet and exercise program, quitting smoking, and learning to deal with stress.

To conclude, bypass surgery has been a landmark in our fight against coronary artery disease. This is an exquisite application of common sense employing body’s own vessels as alternate paths to deliver blood to viatal parts of heart. The operation has seen many advances and is being done as a routine in many centres. The operative mortality is very acceptable and most patients are back to work in four weeks and most can go back to the previous level of activity.

Heart Transplant - Is it a Viable Option?
“Heart transplants have been successfully performed since 1967. Latest figures tell us that 85 percent of those who receive heart transplants survive for more than one year, and 70 percent live five years following the procedure,” I told John Plant, a 40 years old bank with a dilated and poorly pumping heart. He had been in and out of the hospital many times in the last six months. He was on maximal treatment but his effort tolerance remained severely impaired. We had proposed ‘heart transplant’ to him and his first knee jerk reaction was a big ‘no’. “A dream has been transformed into a reality and many patients are enjoying nearly normal life after heart transplant. Today’s heart transplant recipients live longer after surgery than those who received heart transplants just 10 years ago. Many transplant patients go back to work and many participate in moderately strenuous activities, such as walking, swimming and even running,” I added to convince him and eventually he agreed to go for it. Two years down the lane, he was active, playing golf and enjoying holidays in Paris.

Heart transplant has emerged as an established safe and effective theraphy for patients with severe heart problems. Technique of heart transplantation has made great strides of development over the years. Indeed it is a major surgery, in which a severely diseased or damaged heart is replaced with a healthy heart from a recently deceased person. Mortality during surgery is acceptable and the biggest problems are find a heart and prevention of rejection. Patients continue to face a lengthy waiting list to receive a donor heart. According to the recent figures approximately 3,800 patients were waiting for a heart transplant as of June 2007. Only 2,148 people received a donated heart in 2007. According to the American Heart Association, at the present time all over the world, the majority of heart transplant patients were while males. More than half are between the ages of 50 and 64, and about 20 percent are between the ages of 35 and 49. Researches are working to develop equipment to improve the health and comfort for patients waiting for a donor heart and, ideally, to develop a mechanical heart that could permanently solve the shortage problem.

Who needs heart transplant?
When a patient is diagnosed as having an end-stage heart disease, and all medical interventions have failed, and the patient is stable enough to sustain a major surgery then he or she is considered for transplant. End stage heart disease due to decrease in blood supply – coronary artery disease and disease of heart muscle called cardiomyopathy are the most common conditions that may lead to a heart transplant. Heart diseases due to inborn heart problems which are not amenable to surgery are the most common reasons for heart transplant in children. Patients with failure of a previous bypass and persistent angina and heart failure are considered for heart transplant.

Heart transplants are sometimes performed along with lung transplants for individuals with end-stage lung disease that also involves the heart. These conditions are elevated pressures in right sided circulation called pulmonary hypertension. High blood pressure in blood vessels of lungs arising from right side of heart is consequent to either primary – where the cause is not known or Eisenmenger syndrome where the cause is a congenital heart disease. The condition accounts for nearly half of all heart-lung transplants.

Who donates the heart?
Unlike most organs, the heart can only be obtained from donors who die a “brain death,” meaning that the brain dies while the body remains on life support. Organs are obtained from people who give their consent to have certain organs donated. They can also be obtained by permission of next of kin when a suitable donor is considered to be “brain dead.” Although almost 40 percent of donated kidneys are surgically removed from living donors, most major organ donations (e.g., the heart, lungs and liver) are pledged while living and removed when the donor dies. Because of the great demand for organ donors, generally healthy people are strongly encouraged to become donors.

How the heart is transplanted?

Patients waiting for a donor heart are required to report to the hospital immediately on finding a donor. If the donor heart is in the same hospital as the recipient, then the surgery is performed as soon as all preparations have been made. If the donor heart is being transported by ambulance or by air, then the surgical team responsible for the transfer keeps the hospital team informed of their progress.
When the time is right, the patient is given general anesthesia. An incision is made through the chest and sternum, and the ribs are separated. A heart-lung machine takes over the functions of heart and lungs, freeing heart from its normal function so that it can be removed. Some heart muscle is reserved during extraction to act as a support for the new heart as it is sewn into place. When the new heart is positioned and blood vessels are reattached, a heart incision is closed, heart is restarted and blood circulation and oxygen are stored. The warmth of blood should “wake up” the heart and stimulate it to start beating. If this does not occur, it may be necessary to start the heart using an electric shock (defibrillation). Once blood is flowing through the new heart normally and without any leaks, the heart-lung machine is disconnected and chest incision is closed.

After the heart transplant, patient is kept in ICU and monitored during this critical time by cardiac surgeon, cardiologist and other members of the hospital staff. They watch closely for any signs of heart rejection or infection. Medications that suppress the body’s natural immune system are administered to counter the body’s tendency to reject the new heart, and these medications have dramatically reduced the number of rejections.

Patients are unlikely to be very active in the next couple of days, but should be able to walk around in just three or four days. The total length of a hospital stay after a heart transplant is 10 to 14 days. Once a patient is discharged from the hospital, cardiologist and primary physician provide regular medical support, including biopsies and other diagnostic tests several times a year.

The improved life expectancy of patients after a heart transplant is largely due to a new drug called cyclosporine. It is an immunosuppressive drug that appeared in 1983. From its unique way of suppressing the immune system, cyclosporine has become a mainstay in minimizing the body’s tendency to reject a new heart. This is a major risk associated with transplant surgery. When rejection occurs, the immune system sends out antibodies to destroy the new heart, which is perceived as foreign or ‘invading’ tissue cells. Left unchecked, this rejection can result in extensive damage and failure of the transplanted heart.

Problems after the transplant:
Three main problems associated with transplant are rejection, infection and accelerated atherosclerosis.

a. Rejection: Certain tests are required on a regular basis to predict whether the heart is being rejected. These tests include regular biopsies and serial blood tests. Serial biopsies are done to monitor body’s response to the transplanted heart. This involves using a thin tube to remove a small piece of heart tissue. The tube is inserted through a vein either in the groin or side of the neck. Biopsies are outpatient procedures that can be done in under an hour. They are performed often in the first four months after transplantation and, less frequently, in months and years after that. The risk of transplant failure is three times greater among recipients with high levels of troponin I than those with normal levels of this enzyme.
Patients can monitor themselves, as some symptoms may signal rejection, including dizziness, nausea or vomiting, chest pain, shortness of breath, flu-like symptoms like chills, sore throat and fever. Rejection, however, is not necessarily an irreversible event. It can be controlled with different dosage regimen or timing of medications. Patients are encouraged to immediately contact their transplant centre or team, should any of the above symptoms occur.

b. Infection. Patients are urged to immediately report to their physician if any of the following signs of infection like fever, redness, swelling and drainage of fluid appear.

c. Accelerated atherosclerosis. When patients receive a new heart, they also receive new coronary arteries on the surface of that heart. Although these new coronary arteries may have less blockages than their original coronary arteries, heart transplant recipients are more like to develop coronary artery disease (CAD). This disease is thought to be part of the slow rejection process in the transplanted hearts. About 50 percent of heart transplant patients develop CAD. Therefore, patients must undergo cardiac tests periodically to check for the disease.

A longer-term goal for some researchers is the genetically engineered heart. The organ is composed of human tissues – perhaps one’s own – and is cultured or grown over a period of months to match detailed specifications. Currently, this “heart-in-a-box” project exists only in a university research facility, but researchers have a goal to have cryogenically (defined as ‘low-temperature”; in this case, very cold) stored organs available for transplant in less than a decade.

The dreams of yesterday have worn the attire of reality today. Heart transplant is a viable option in selected patients with heart failure, who do not respond to maximal therapy. Due to recent technological advances, the outlook has improved, survival being more than 83% at one year.

Balloons and Heart
The entry of balloons has heralded a new era in the world of medicine with profound effects in its various important fields. The strongest ripples were however felt in cardiology and specialties dealing with gastroenterology, anaesthesia and urinary system. In cardiology it has revolutionized the approach to many commonly encountered problems. Many more fields await the application of this exciting ‘balloon technology’!

What can balloon do for us? It has been used to track into blood carrying tube – vessels, as air is lighter than blood, so this travels along the course of the vessels. It has been used for retention of a tube in a cavity, with balloon inflated on an end of tube after the entry has been secured prevents its slippage. Similarly it has been used to retain the urinary catheter in the bladder by inflating the balloon at the end. Tubes used in anaesthesia used to have leaking of air around it, that problem is solved by inflating balloon around it. Balloons have been used to arrest bleeding in patients with bleeding varices in dire emergency by exerting direct pressure on bleeding varices.

The biggest breakthrough came with the realization that these balloon could be employed to ‘blow up’ blockages in various parts of body. Balloons of different sizes and quality mounted on different structures have been successfully used for this purpose. They have been used to open up obstructions in gastrointestinal tract without surgery. Blockages in urinary system have been dilated by balloons with minimal patient discomfort and without surgery.

The epic of balloon technology can be witnessed in cardiology where the whole scenario has changed in cardiac catheterization laboratory. Initially cardiac catheterization laboratory was used truly as a laboratory where different diseases were diagnosed based on the information gleaned from catheterization. Now the emphasis is shifting from diagnosis to therapeutics. With the advent of echocardiography, most diseases can be accurately diagnosed without cardiac catheterization. In cardiac cath lab, catheter based therapeutics is predominantly dependent on “poor old balloon”, small balloons blowing up obstruction in coronary and other vessels with excellent results and large balloons opening up narrowed valves with enviable results obviating the need for surgery.

Valvuloplasty:
Large balloons ranging from 10 to 30 mm in diameter are used to open up different valves. Obviously, size of balloon depends on the target and size of patient. These valves are either congenitally narrow or narrow down in later life due to various disease process. Previously surgery was required to open up the stenosed valves and remove the impediments in blood flow. Not any more! The procedure is performed without anaesthesia. As an initial step baseline data is recorded, then access beyond the narrowed valve is secured by manipulating a flexible catheter across it. A long wire is left across the valve and a narrow balloon mounted catheter is manipulated on the wire across the narrowed valve. Once satisfied with the position, the balloon is inflated, first a waist appears confirming the impinging valve on balloon and then it slowly gives way. The The valve is open! No ugly scar on chest, no confinement to bed for days, no need for prolonged antibiotics, no loss of work and the beauty is that the patient can actually walk home the next day.

Obviously these balloon mounted catheters are made of very sophisticated material and a lot of research has been done to perfect the technique and hardware. The catheter system to open Mitral valve is named after Inoue. The only way to cut down the costs are to reuse the balloon after proper sterilization. The chances of success are more than ninety five percent and complication rate is quite low. The balloon used for Pulmonic and Aortic valves are different in size and shape.

Angioplasty (PCI)
Balloon have only recently been tamed, to be used in small vessels supplying heart. It started with Andrea Grundzick in 1979, when a blockage in a vessel was opened in a patient. Since then there has been an explosion in the cath lab of angioplasties. In USA, it is called ‘occulo dilating reflex’ which implies that as soon as a cardiologist sees an obstruction in a vessel, he has an irrepressible urge to dilate it. Or, according to our not very good friends, cardiologists on seeing a blockage develop severe stomach ache which can only be relived on opening up that lesion. No doubt there has been a mad race in opening of the lesions and technology is witnessing tremendous progress in this field.

Most research taking place in cardiology is focused on small balloons used in vessels supplying heart. The aim is to produce tough balloons which can endure high pressure without deforming, mounted on catheter which should have very small profile so that it can negotiate the bends and cross the blockage, the catheters should have enough strength to be pushed around and cross the lesion. Similar research is taking place in paraphernalia like catheter and guide wire.

How is it done? After identifying the blockage a strategy is devised regarding the approach and hardware to be employed. The procedure is similar to angiography where no anaesthesia is administered. After doing angiography, the lesion is crossed with the help of a very find guide wire. Care is taken to float this wire across the lesion preventing it from going to small branches. It is like going through a large tree to a specific branch which might take a minute or a couple of hours. Once the lesion is crossed balloon mounted catheter is introduced and parked at the lesion. The size of balloon chosen depends on the size of the vessel. Satisfied with the position of catheter, the balloon is inflated under X-ray control. Patient experiences pain when balloon is inflated as blood supply to a part of heart is totally prevented. The balloon is kept inflated for as long as a patient can tolerate, varying from a few seconds to a minute. The appearance of waist and later giving way is apparent on X-ray. The lesion gives way with increase in lumen size.

Balloon are also being used to dilate obstructions in vessels supplying brain, kidneys and extremities. New territories are being ventured into and with the development of proper hardware the need for surgery will be obviated in most cases.

Introduction of balloon technology is a fine example of application of common sense to common problems. Balloons have been used for retention, and opening up blockages. This has proven to be a major advance in medicine and surgery and almost all specialties are benefiting from this simple but very exciting technology.

Beyond Balloons and Springs
“You people have been creating havoc in tiny little coronary arteries of the heart, what are you people up to now?” is a question very commonly asked. “Nothing much, after blowing up balloons in the depths of chest, now we are venturing on new territories. Shaving off plaque has been on the cards for a long time with the help of ‘atherectomy’ devices, we have been putting up strong metal scaffolding ‘Stents’ in certain obstructions and using laser in the vessels either to create holes or increase the lumen size. Radiotherapy is being used to prevent restenosis. The name of the game is to enlarge the lumen size with balloon or some other technology,” I brief the gentlemen inquisitive about new technology and his heart, “the other major advance had been to put tiny ultrasound probe mounted catheter into the vessels hence opening a new window to study the vessel before and after the dilatation.”

Balloons have been used for tracking, retention, prevention of leakage, and opening up of stenosis in vessels, valves or other organs. They have been used to track into blood carrying vessels as air is lighter than blood so this travels along the course of the vessel. Swan Ganz catheters are balloon mounted catheters used for pulmonary artery and left heart pressure measurement and determination of cardiac output. Similar balloon tipped catheters have been used as temporary transvenous pacemaker lead. Balloons have been used for retention of the tube in a cavity with balloon inflated on an end of tube after the entry has been secured to prevent its slippage. Most commonly this technique is employed to retain the urinary catheter in the bladed by inflating the balloon at the end.

___________________________________________________
Ref: Heal Thy Heart written by Prof: Dr. Muhammad Hafizullah

Read more...

ARTICLE XVII - Clopidogrel – The Drug of Tomorrow!

0 comments
Very few drugs have been received in the world of medicine with so much enthusiasm as Clopidogrel. It is one of the few drugs which received wide spread acceptance in its ‘infancy’. It was introduced in the world as Plavix but is available in the country under more than a dozen names like Cloxidil, Noclot, Lowplat, Ogrel, Dogrel, Clogrel, Deplat, Deplug, Platagg, Cumplat etc. Antiplatelet drugs are useful means of preventing acute blockages of vessels causing occlusions in cardiovascular diseases. Clopidogrel is a thienopyridine compound and produces irreversible platelet inhibition.

Clpidogrel inhibits platelet aggregation and that can be seen 2 hours after single oral dose of clopidogrel. Early and more pronounced inhibition can be achieved by using a loading dose using 4-8 tablets providing 300 – 600 mg. Such doeses are used when early inhibition of platelets is required in emergency situations like angioplasty and stenting in unprepared patients and patients presenting with unstable angina and heart attack. Repeated doses of 75 mg clopidogrel per day inhibit platelet aggregation on the first day, and inhibition reaches a steady state between Day 3 and Day 7. Plateleet aggregation and bleeding time gradually return to baseline values after treatment is discontinued, generally in about 5 days. Absorption is rapid and is not affected by food or antacids. It is extensively metabolized through liver and the elimination half-life is 8 hours.

Many major trials have been conducted to test the efficacy and safety of the drug in various expanding list of indications.

1. Clopidogrel in Angina:

In a large trial employing patients from 16 countries was carried for three years. The aim was to assess the relative efficacy of Clopidogrel and aspirin in reducing the risk of storke, heart attack, or vascular death. There was a relative-risk reduction in favor of Clopidogrel. There were no major differences in terms of safety for both Clopidogrel and Aspirin. So it proved that Clopidogrel was as effective as Aspirin in patients with stable angina and Clopidogrel can be used in patients who cannot tolerate Aspirin.

2. Clopidogrel in Unstable Angina:

Clopidogrel has become the drug of choice in patients presenting with unstable angina. The drug was studied in patients presenting with unstable angina in a study called CURE – Clopidogrel in unstable angina to prevent recurrent events. The aim was to assess the safety and efficacy of combination of clopidogrel and aspirin in tweleve thousand patients presenting within 24 hours of unstable angina. There were significant reduction in primary and secondary outcomes. Significantly fewer patients had recurrent chest pain and underwent angioplasty or surgery. Overall, there was no significant excess of major bleeding episodes after coronary grafting.

3. Clopidogrel in Heart Attack:
The effects of Clopidogrel were studied in a large study employing patients from many centres in China. The trial proved that adding Clopidogrel to Aspirin in acute heart attack prevents around ten major vascular event per thousand treated. There was no excess bleeding in breain-fatal or major. The result confirmed that each million heart attack patients treated for more than two weeks would avoid 5000 deaths and 5000 non-fatal events. Nowe it has become manadatory to administer loading dose 4-8 tablets to patients after a heart attack as soon as possible.

4. Clopidogrel in Angioplasty and Stenting:
One of the major advantages of Clopidogrel lies in prevention of clot formation in patients undergoing stenting with different types of stents. In a large study, patients planned for percutaneous coronary intervention (PCI) were randomized to either Clopidogrel and Aspirin as a loading dose or placebo and aspirin prior to PCI. Patients receiving Clopidogrel with Aspirin showed fewer cases of acute blockage due to clots in the stent. Recent guidelines dictate to start Clopidogrel a few days before the procedure or administer loading dosage of Clopidogrel immediately before the procedure.

The long term effects of antiplatelet therapy in patients following PCI have been evaluated in many trials. The drug has to be continued for long term (3-12 months) in patients receiving bare metal stents and one year to indefinite in those receiving drug eluting stent. The rationale behind this recommendation being the delayed healing of inside layer – endothelium of the vessel after drug eluting stent.

5. Stroke and Transient Ischaemic Attacks:
Clopidogrel is the focus of research in many fields in Cardiology, vascular medicine and neurology. It has been shown to produce salutary effects in prevention of stroke in patients with minor strokes called transient ischemic attack (TIA). Further strokes can be prevented by using Clopidogrel in ischemic stroke patients.

6. Peripheral Vascular Disease:
Clopidogrel has been evaluated in patients with blockages in vessels supplying arms and legs and internal organs. It has been used after surgery, angioplasty and stenting in such vessels and also when intervention is required, with gratifying results. A large trial is being conducted, focusing peripheral arterial disease patients.

7. Irregular Beating of Heart:
Patients with irregular beating of hear called atrial fibrillation develop pooling of blood in left sided storage chamber called left atrium. This stasis of blood can lead to formation of clot, which can dislodge and hit any vessel/part of the body. This results in blockage of that vessel hence cessation fo blood supply to that organ or part. Stroke and heart attack can be result of embolism of clot to brain or heart. Blood can be thinned down and such clots can be prevented by using Dispirin and Clopidogrel on their own or in combination.

Clopidogrel Compared To Other Antiplatelet:
It has some major advantages over ticlopidine – another potent antiplatelet drug. Clopidogrel is six times more potent thatn ticlopidine. It has reduced metabolic burden on liver – the main site of clearance. It has an improved benefit/risk ratio. Clopidogrel related reduction in white blood cells called neutropenia has not been reported whereas all of the earlier trials on ticlopidine reported severe neutropenia.

Side Effects Associated with Clopidogrel:
Clopidogrell may cause side effects, most frequent side effects are rash, bleeding, gastrointestinal upset, and gastro –intestinal bleeding. The personal physician should be informed if a patient experiences excessive tiredness, headache, dizziness, upset stomach, stomach pain, diarrhea, or nose blood. Some side effects can be serious. The following symptoms are uncommon, but if experienced one should report to doctor immediately; black and tarry stools, blood in stools, bloody vomit, vomiting material that looks like coffee ground, unusual bleeding or bruising, fever, sore throat, chills, and other sings of infection, slow or difficult speech, weakness or numbness of an arm or a leg or vision loss.

Clopidogrel is a novel antiplatelet, has definite advantages over aspirin like less severe gastro intestinal bleeding and superiority in reducing major ischemic events. In most of clinical indications clopidogrel is combined with aspirin but it can safely substitute aspirin if the drug cannot be tolerated due to stomach upet. With every passing day, newer indications are being discovered. There has been an exponential increase in the usage of the drug on both sides of Atlantic. All this has been possible because of well conducted mega trials proving the efficacy and safety in large groups of patients.

___________________________________________________
Ref: Heal Thy Heart written by Prof: Dr. Muhammad Hafizullah

Read more...

ARTICLE XVI - Aspirin – A Panacea?

0 comments
If Aspirin was to be discovered today, the discoverer will be a nominee for Nobel prize and the drug will be sold in the market fifty times of its current price. This has been one of the most ‘wonderful’ discoveries in the world of science but the credit goes to the ‘rediscovery’ of its many ‘potentials’. The story of Aspirin is that of ‘rags to riches’ starting from a very humble background, it has become one of the most widely prescribed drugs. To start with, it was used only as a pain killer and now it has an application in almost all the fields of medicine directly and indirectly.

The strongest effects have been felt in the field of cardiology. Anyone with the diagnosis of a heart ailment has to have Aspirin. There was a time when ‘digoxin’ was synonymous with cardiac problems and every one with the ‘possibility’ of a heart problem would be prescribed the drug, the same is now true for aspirin. More than that we have entered in an era where it is being ‘over prescribed’ and we have to make special efforts to rationalize its usage to the ones who really need to have it.

The utility of Aspirin has been proven in the courts of statistics – the world of numbers by conducting large clinical trials where it was tested in a ‘blind’ fashion again placebo and other drugs. The results are very impressive and highly significant. The essential role of Aspirin is to reduce the aggregability or stickiness of an important constituent of blood called platelets. Platelets stick together and form a plug which blocks the tubes carrying the nutrition – blood. Hence they reduce or in many cases totally block the blood supply to a part of body which may happen to be heart, brain or kidney.

There is an elaborate system of blood supply, operating in the body which ensures optimal nutrition/blood to each and every part of body and at the same time same medium is used for getting rid of toxic material. Any blockage in the system causes reduction of blood supply to that particular part of body which results in impairment of function of that part or system. Some of the blockages may be due to inborn problems but mostly they are due to the process of atherosclerosis (athero – cheesy and sclerosis-hardening). This is a process by which cheesy material is deposited inside the tube or vessels. This process starts early in life and is progressive. Known risk factors like diabetes, high blood pressure, high cholesterol and smoking predispose to this process and accelerate it. On top of these blockages blood supply may be further reduced with the formation of platelets plugs. Aspirin prevents formation of these plugs hence it has its application in preserving the blood supply to all the systems of the body.

The major advantage is found in preventing the blockage in the blood supply system to heart and brain. It is an important player in ischaemic heart disease presenting as angina, acute coronary syndrome and heart attack. The most convincing effects are seen in the setting of acute myocardial infarction where Aspirin is recommended to be chewed for quick action as soon as possible. Very few treatment modalities have been so well and widely received and practiced as aspirin in heart attack. Aspirin in does of 40 mg can acetylate all the platelet cyclo-oxycenase hence reducing the aggregation property of platelets. In a summary of 33 trials conducted in heart attack, mortalilty in patients on aspirin was reduced from 25% to 11%. The effects are comparable to the use of clot dissolving drugs like streptokinase. It is mandatory for all doctors and paramedical staff to administer a tablet of Aspirin to anyone who presents with chest pain and is suspected to have a heart attack. In the setting of CCU first thing to be given to the patient should be Aspirin. Many doctors carry Aspirin with them, to be taken in case of an emergency.

In patients presenting with unstable angina or acute coronary syndrome Aspirin has been shown to be highly effective in reducing platelets stickiness and restoring blood supply to heart. The usage has been shown to reduce the complications and further progress of disease. Similar salutary effects are seen in patients labeled as stable angina experiencing chest pain on exertion. Every patient with suspicion of heart attack, unstable angina or stable angina should take Aspirin and continue indefinitely in dosage of 75mg per day. Various enteric coated brands are available in the market to reduce hyperacidity.

As a step further, Aspirin is being recommended for patients who have risk factors for developing heart problems. In patients who are diabetic, have high blood pressure or elevated cholesterol, the introduction of Aspirin has been shown to decrease the risks for further problems. Many doctors recommend Aspirin to all the patients above forty years of age, regardless of other risk factors. The evidence to support such treatment is not very robust. In the present day scenario Aspirin is being used in all the presentations and even for the prevention of Ishaemic heart disease.

Aspirin has been used for ages as a first choice in a disease which afflicts the joints and heart at the same time called rheumatic fever. This is a disease, still quite prevalent in the developing countries, in the lower social strata and in childhood. This results in damaging the valves-doors of heart causing heart failure in young children. Many of these children require operation of the valve and some succumb to it. The response to Aspirin is dramatic and quick. The response is taken as evidence of the validity of the diagnosis.

The usage has increased in other cardiovascular diseases where platelets are discouraged to stick together and form clumps. Patients with irregular beating of heart called a trial fibrillation have the propensity of clot formation due to whirling of blood in left storing chamber. These clots can get dislodged and find their way into different circulations. Aspirin is indicated in such situations to prevent clump formation and prevention of stroke.

Aspirin is being used for the prevention of stroke and in patients of transient ischaemic attacks (TIA) enthusiastically in the light of over whelming evidence provided by many large well conducted trials. An analogy can be drawn between stroke and TIA to heart attack and acute coronary syndrome respectively. Blockages in blood supply produce symptoms and these blockages can be prevented by Aspirin. Same as ischaemic heart disease, people at a higher risk of developing stroke are treated with Aspirin for the prevention. Same risk factors as for heart attack are taken into account and treated aggressively.

A unique role for Aspirin has been discovered in pregnancy. Certain patients go into premature labour before their due time. Aspirin plays an important role in preventing that through its action on arachidonic acid. This has been a new tool in the hands of Obstetricians with very good response.

Aspirin can potentially cause gastric erosions and ulcers beside hyperacidity. Paitnets with proven ulcer on endoscopy or barium meal, history of gastrointestinal bleeding or thos receiving antiulcer treatment should not be given aspirin. Patients with known allergy should not be given aspirin. Other platelet inhibitors may be considered in patients who have allergy or who cannot tolerate aspirin.

___________________________________________________
Ref: Heal Thy Heart written by Prof: Dr. Muhammad Hafizullah

Read more...

Tuesday, June 30, 2009

ARTICLE XV - Beta Blockers – An Answer to All Problems!

0 comments
The drug that is closest to the heart of cardiologists and most widely prescribed for a variety of indications. Literally responsible for saving millions of lives every year and making people survive through the painful angina and even drag them out of the hopelessness of myocardial infarction. The drug that is used most extensively for high blood pressure and which has given a new lease of life to patients with cardiac failure. The drug that is being used for anxiety and migraine in millions of patients in the general practice – this drug is called BETA BLOCKER.

Let’s explore the role of this group in many cardiac problems starting from high blood pressure to heart failure and heart attack.

HYPERTENSION AND BETA BLOCKERS:
Beta-blockers makes the heart beat more slowly and less strongly. They work by blocking the action of nerves supplying the heart that release a chemical called Noradrenalin. This helps to control the rhythm and force of heart muscle movement. It also effects and tones down the central sympathetic activity. Beta blockers have been in the forefront of antihypertensive arsenal for the last two decades. They have been shown to be highly effective in reducing systolic and diastolic blood pressure specially in persons with high sympathetic drive or who are tense. They are effective in reducing total death rate, strokes and kidney failure in patients with high blood pressure. Beta blockers can effectively reduce the thickness of muscle of heart due to high blood pressure. Beta blockers are well tolerated by a majority of patients and have been found to very safe in all age groups and both genders. They have a special role to play in patients with compelling indications like angina, heart attack, and heart failure. This is the only group of drugs to show reduction in heart attacks in white, non smoker males.

Being highly effective drugs with extremely safe profile, the group has earned a special place, for itself in the drugs used for hypertension. These are the most commonly used and often the drug of first choice for this indication.

ANGINA AND BETA BLOCKERS
The commonest presentation of Coronary artery disease – when a person develops blockages in the blood supply of heart, is angina. Physical or mental stress leads to increasing heart rate and blood pressure, which leads to chest pain called angina. Beta-blocker slow the heart rate and reduce the heart’s workload. When the heart does not have to work as hard, it requires less oxygen. This in turn can help relieve or prevent chest pain (angina). To treat and prevent these pains, beta blockers have proved to be very effective. Beta-blockers are often used with the medications to treat angina. Beta blockers are the drugs of first choice in most patients presenting with angina. There is ample data to support its role in angina where it decreases the frequency of angina episodes and increase effort tolerance/ exercise capacity. The severity of anginal attacks decreases markedly with Beta blockers.

Role of beta blockers in Heart attack:
Heart attack is a common presentation of coronary heart disease. Here the blood supply to a part of heart blocks completely causing death of that portion of heart. There are two ways to approach a patient with myocardial infarction. The first one is opening the blockages in arteries to re-initiate blood going to the heart, the other one is decreasing the demand of blood supply to muscles of heart and this is what this magical drug does. Beta blockers have been shown to reduce the size of myocardial infarct – dead portion of heart in animal and human models. Beta blockers reduce lipolysis, that is the break down of fats. Beta-blockers given within hours of the start of a heart attack reduce both the risk of death and recurrent heart attack. They have well established anti-ischemic, anti-arrhythmic and anti-hypertensive effects. Large trials have shown impressive reduction of morbidity and mortality with oral and intravenous beta blockers. Evidence strongly suggests that most people should take beta-blockers for at least 6 months and may be two years after a heart attack, and probably longer to get the most benefit. It applied to both genders regardless of age. It is a must for all those who suffer from hypertension. The intake is oral and should be taken continually for about two years. Almost all drugs show similar effects, although water soluble beta blockers have a clear advantage over others. But for people who have asthma and hypotension, this drug is not recommended, however controlled diabetes is not a contraindication to beta blockers as the benefits outweigh the hazards.

Role of Beta-Blockers in Heart Failure
Heart failure is a significant public health problem effecting 15 million people world wide. There has been an increasing incidence of heart failure in contrast to the decreasing incidence of heart diseases. The associated hazards as found in Framingham study, mortality rate 17% in one year, 30% in two years and 50% in five years.

For the past 40 years medical students have been taught to avoid Beta Blockers in heart failure. Beta Blockers work by blocking adrenaline which increases force of contraction of heart muscle and improve its performance. Beta blockers are like double edged sword. Due to their negative effects on heart rate and contractility, they can worsen the heart failure but, used properly and judiciously they ameliorate the patients status and have salutary effects on the clinical status, exercise capacity and reduce death rate. This has been one of the most wonderful ‘rediscovery’ of the effects of beta blockers. This is also an example of how clinical experience and experimentation can alter the course of action and carve new place.

Many large trials have been conducted to evaluate the efficacy of beta blockers in large populations with mild, moderate and severe heart failure and patients with left ventricular dysfunction after a heart attack. There was a definite and marked reduction in mortality. All cause mortality and hospitalization was reduced significantly. Hospitalization due to any cause was reduced markedly.

Who are the patients that will benefit from beta blockers therapy? All patients with mild, moderate or severe but compensated heart failure on standard treatment of ACE Inhibitors and diuretics are candidates for beta blockers. There are important points to be kept in mind as only stable patients should start beta blockers. Preferably, doses should not be changed of ACE Inhibitors for one month and diuretics for 2 weeks. Ideally patients should not have required intravenous supporting drugs in the last one month.

This is an exercise that requires persistence and patience! One has to start with a very small does and then the dose has to be increased very slowly over weeks while monitoring heart failure status, blood pressure and heart rate. Some patients may deteriorate initially, that is why persistence is very important and patients have to be encouraged to adhere to the therapy. Many patients may not see any change in their clinical status initially that is why patience is required and patients have to be motivated to hold on to the treatment.

Various trials have now documented that Beta Blockers used carefully reduce heart failure symptoms and improve the quality of life. Beta blockers have been shown to reduce the risk of all cause mortality, such as sudden death and death from progression of heart failure. Beta blockers have been effective in reducing hospitalization. Compelling evidence now exists to support the safety and efficiency of Beta Blocker therapy in heart failure.

What are the specific side effects? Patients may complains of fatigue, slow heart rate and low blood pressure. Speciation caution has to be exercised in patients with reactive airway disease and decompensated stated.

Tachycardias:
Many patients with structurally normal heart have the propensity to develop very fast beating of heart – tachycardia, presenting as palpitations, fluttering or loss of consciousness in severe cases. Because of their effects on sinus node and AV node – two important pulse generators, this fast beating can be effectively controlled. The drug may be used intravenously for immediate effects and it is effective in most cases. It is used in oral preparation for the prevention of further attacks.

Other cardiac problems:
Beta blockers have found an application in many other fields.

· It is used to relieve the obstruction in patients presenting with severe outflow obstruction like right pumping chamber outflow obstruction.
· It is effective in reducing heart rate where patient has very fast heart rate specially accompanied by obstruction like narrowing of the valve – door between left storing and pumping chambers.
· It is used effectively in reducing rapid and powerful contraction in patients with markedly thickened interventricular septum called hypertrophic obstructive cardiomyopathy HOCM.

Miscellaneous:
There was a time when newer indications were found for the usage of beta blockers every week. The drug was tried and many times quite successfully in many scenarios outside the world of cardiology.

· The drug alleviates anxiety and are used by many for allaying anxiety in stressful situations like presentations, examinations and speeches. They do not impair intellectual powers but reduce the ‘fast beating’ of heart and the unwanted ‘tremors’ and ‘cold sweat’. These drugs are used extensively by psychiatrists, all over the world, for reducing anxiety and counter the tachycardic effects of some drugs.
· They are used for tremors – mainly senile tremors.
· Many people with migraine (headaches) have been able to reduce the severity and frequency of episodes.
· Beta blockers are used in patients with liver disease like Cirrhosis for reduction of pressure in liver.
· They are used in patients with thyroid gland hyperactivity called thyrotoxicosis for controlling their symptoms.

Side Effects
Like all potent drugs beta blockers have side effects and pros and cons have to be weighed for all clinical conditions and patients. Side effects of beta-blockers may include lack of energy or drive, fatigue, vivid dreams and erection problems (impotence). It can decrease blood flow to fee and hands, causing them to feel cold and increase leg pain brought on by exertion (intermittent claudication). May cause dizziness and lightheadedness, more likely to occur when started or when the dose is increased. In people with diabetes, beta-blockers can insignificantly increase blood sugar levels. More importantly beta blockers may mask warning signs of low blood sugar, such as increase in pulse rate and sweating. Beta-blockers may worsen medical conditions such as asthma, heart failure, and certain heart arrhythmias. Beta-blockers should not be stopped without first discussing with the doctor. The risk of heart attack may be increased when beta-blockers are stopped suddenly.

Beta blockers are drugs with multiple actions and have been used in many cardiac diseases like high blood pressure, angina, heart attack and heart failure. They have wide-spread applications in non cardiology world. By and large they are well tolerated and have certain side effects which have to be watched.

_____________________________________________
Ref: Heal Thy Heart written by Prof: Dr. Muhammad Hafizullah

Read more...

ARTICLE XII - How to pass the ‘Failed Heart’ (Part-I)

0 comments
“No, this is not possible, I cannot have heart failure,” said Abdul Qayyum, 50 years old bureaucrat with clenched fists and raised eyebrows. His argument were, “I can walk around and attend my office, so I cannot be too unwell!”It took him some time to accept the diagnosis. His next question was, “Is it the end of story? Shall I ask for retirement and confine my activities?” He was very happy to learn that firstly, heart failure was not synonymous with cardiac arrest/death and secondly, near to normal life was possible with new medical treatment. Some new drugs have effects on improving the outlook of disease and new technology is evolving to mitigate the suffering of patients with heart failure.

Heart failure is the end result of many diseases that effect the heart. Some diseases effect muscles of heart either through infections or deprivation of blood supply – coronary artery disease. Certain diseases effect the doors of heart called valves, either by restricting their motion or rendering them incompetent and leaky. High blood pressure puts extra load on heart and heart muscle has to generate higher pressure to pump blood. This extra effort taxes heart and eventually leads to heart failure. Heart tries to compensate by either beating fast or increasing in size, but eventually gives in. This stage is called heart failure as heart cannot meet the demands of body.

For the management of heart failure, prompt and accurate diagnosis of the disease causing heart failure is of paramount importance. There are several causes of heart failure. Several different tests are required to determine the exact cause of heart failure. In some cases the cause of heart failure can be reversible (such as a heart valve defect) or treatable (such as a thyroid problem) but in a majority of cases drug treatment is used to reduce the symptoms and improve the outlook.

How to work up heart failure? In patients with symptoms suggestive of heart failure, many tests may be required. Recently there has been a lot of research on a special blood test called brain natriuretic peptide (BNP), which can be used to diagnose heart failure and correlates well with severity of failure. The level rises when heart failure worsens. Electrocardiography (ECG) and Chest X-ray are the bare minimum cardiac tests. Echocardiography (echo) is the best and simplest way to determine heart function and whether it is systolic or diastolic heart failure. Echocardiography can also help to determine the cause of heart failure and help guide treatment decisions.

Nuclear scanning – a non invasive nuclear test is done to identify areas of the heart that are not receiving adequate blood flow (ischemic areas) and assess the left ventricle’s ability to function. Cardiac blood pool scan (radionuclide ventriculography) is often used when echocardiography results are less likely to be accurate due to a person’s weight or breast size of the presence of severe lung disease. Radionuclide ventriculography provides an accurate method for assessing the pumping ability of the left ventricle. However, it is less useful for evaluating the presence of heart valve disease and thickening of the heart muscle. ThalliumRadionuclide ventriculography provides an accurate method for assessing the pumping ability of the left ventricle. However, it is less useful for evaluating the presence of heart valve disease and thickening of the heart muscle. ThalliumRadionuclide ventriculography provides an accurate method for assessing the pumping ability of the left ventricle. However, it is less useful for evaluating the presence of heart valve disease and thickening of the heart muscle. Thallium/MIBI scan can detect reduced blood flow to heart. Cardiac catheterization and angiography can be used to identify blocked or narrowed coronary arteries and to measure pressures inside heart. Test results can help diagnose conditions that might cause or worsen heart failure symptoms.

_____________________________________________
Ref: Heal Thy Heart written by Prof: Dr. Muhammad Hafizullah

Read more...

ARTICLE XI - So you had a Heart Attack – What next!

0 comments
Khalid seemed visibly upset and was trying to hold back his tears. He was in his early forties and had just entered his pratical life. He had two small kids and a very lucrative job. He had many dreams and many unfulfilled plans. He was perfectly healthy so far and it had not occurred to him in his wildest dreams that he will end up in CCU one day. But as luck would have it, he suffered a heart attack one morning, and here he was in CCU on the second day of his admission.

I could see a hot of questions written all over his face. Is it the end of his career and will he lead a nearly crippled life? Does it imply that he will be confined to his house for the rest of his life? Does it mean that he necessarily has to go for a bypass operation< Will he not be able to enjoy golf again? Does he have to remain content with a boiled diet without any meat? Should he pursue his MBA degree? Should he still consider an addition in his family?

Heart attack can mean different things to different people. For most patients it is an important event but it passes off like another event and the person can go back to normal life. There is a definite mortality attached to it. Half of the persons who die of heart attack die within first hour and that too because of irregular beating of heart. In a few cases, it is not even recognized as a heart attack. Later, once patient is stable in CCU and has received definitive treatment then the death rate does down. Ninety percent of patients will leave CCU and hospital alive on their feet.

There was a time when patients were kept in the hospital for weeks and they were not allowed to lave the bed for a month. Things have changed for the better! Patients who are otherwise stable are mobilized after forty eight hours. They are discharged if they are otherwise stable on third or fourth day. If they have any problems – mechanical or electrical, they are kept under observation for as long as necessary. Patients who undergo angioplasty after heart attack may be discharged the next day and allowed to return to work much earlier. Patients are advised rest and leave from work for four weeks. Gradual mobilization is recommended after discharge. Starting from ten minutes on an empty stomach at a leisurely pace morning and evening and then building it up slowly to thirty minutes twice a day. Most patients can expect to go to work after four weeks.

When and what tests does one require after a heart attack? The basic philosophy is firstly to document the extent of damage in terms of function of left ventricle – main pump. Secondly, determine the extent of blockages in vessels supplying heart – coronary arteries, and thirdly look for all risk factors and try to improve them. Most patients will be required to undertake tests like effort tolerance test and echocardiography. This is to identify patients who will be requiring further tests like coronary angiography and hence requiring interventions like angioplasty and bypass operation. Not every patient who suffers from heart attack needs angiography or bypass surgery. Patients on very demanding and physically tough jobs or those who are young are advised coronary angiography irrespective of the result of effort tolerance test.

Big question for the family is what to allow the patient to eat? Many patients on their first visit after heart attack bring their youngest child who demands a list of forbidden food. This young lad turns out to be mama’s detective on a special duty. Depending on other risk factors like diabetes, high blood pressure and high cholesterol, there is not a lot that a patient should be denied. Preferably, food should be low in cholesterol within no ghee, butter, fat, egg, and internal organs. Small quantity of chicken and meat are allowed and fish is encouraged. No bar on bread or rice unless the patient is fat and calories have to be watched. Soups are allowed but should not replace normal food. Some roughage in the form of salad and fresh or boiled vegetables should be encouraged as it prevents constipation. Half cream or skimmed milk may be consumed. Juices especially fresh may be encouraged if the patient is not diabetic. Fresh fruits are always welcome.

Most patients are able to retain their job and follow their pursuits unless it is very risky and demanding. A few months down the lane most people will have forgotten about the event and gone back to their old life styles. Competitive sports and jobs in armed forces may be difficult to retain. Most intellectuals and bureaucrats have had a heart attack by the fifth decade but they continue to follow their jobs and hobbies.

Can one have another heart attack after the first one? Why not! So one has to put in efforts to correct one’s risk profile. For those who are diabetic, blood sugar level has to be meticulously controlled by keeping a very vigilant watch on diet and taking prescribed medicines regularly. Patients with high blood pressure have to bring their blood pressure to normal range or lower than that. Salt has to be restricted and treatment plan adhered to. Cholesterol has to be brought down regardless of the baseline levels. Strict control on diet is required and nowadays we are very liberal in prescribing cholesterol lowering drugs like statins. They have been shown very convincingly to reduce deaths and requirement of angiography and interventions like bypass and angioplasty in treated patients with salutary effects on lipid profile.

With modern treatment, like clot dissolving drugs and angioplasty – opening of vessels with balloons and stents, the outlook has improved remarkably. Most patients can go back to their original job and life style in four weeks. Regular exercise, discretion in diet and adherence to treatment are the golden rules to follow. For the majority of patients who sustain a heart attack, it is not the end of the world!

_____________________________________________
Ref: Heal Thy Heart written by Prof: Dr. Muhammad Hafizullah

Read more...

Monday, June 29, 2009

Article X - Management of Heart Attack – the Recent Advances!

0 comments

The immediate management of heart attack called acute myocardial infarction, entails accurate and prompt diagnosis of heart attack based on history, ECG and blood test for release of cardiac enzymes. For monitoring and definitive treatment, quick assessment and early referral to a coronary care unit (CCU) is required. Management includes general measure and drugs – pharmacotherapy. Effort has been made to describe various strategies and drugs under the headings of rationale and evidence, indications, protocol and dosage and precaution.

MOBILITY:

Patient is confined to bed for the first 24 hours being monitored in CCU. Patients with persistent chest pain, irregular beating of heart called arrhythmias or heart failure are immobilized for longer duration. In uncomplicated heart attack gradual mobilization according to a set protocol should be followed.

OXYGEN:
Rationale and Evidence
Increased oxygen concentration is helpful at the time of heart attack to protect jeopardized heart muscle. It is helpful in reducing ventilation and perfusion mismatch. Administration of 100% oxygen has been shown to reduce ECG changes and have some effect on reduction of heart attack severity and size in animal and human models.

Who should get it?
Supplemental oxygen to all patients with overt breathlessness and those who have low oxygen saturation. Routinely it may be administered to all the patients with uncomplicated heart attack during the first 2-3 hours. There is no convincing evidence of any significant benefit in uncomplicated heart attack beyond 3 hours. Oxygen may be administered by nasal prongs or mask. The rate may be adjusted in arterial desaturation guided by repeat estimation. Nasal prongs may cause nasal irritation and mask may cause claustrophobia.

PAIN KILLERS
Rationale and Evidence:

Heart attack pain is very severe and capricious accompanied with impending feeling of death. Pain increased sympathetic activity hence increasing oxygen metabolic demand. This has to be relieved in shortest possible time with effective analgesics in appropriate dosage through proper route and repeated at proper intervals.

Who should get it?
Every patient with severe chest pain with ECG evidence should receive adequate analgesics. Those patients presenting after pain resolution may not be candidates for analgesics.

Precaution:
Morphine and analogues may depress breathing and extra caution must be exercised in old patients and those with chronic chest problems. Morphine and analogues cause vomiting, so anti-emetics should be given prophylactically.

CLOT DISSOLVING TREATMENT (Thrombolytic therapy):
Rationale and Evidence:
Last decade has been the decade of clot dissolving drugs called Thrombolytics. Convincing evidence from many large trials involving large patient population has secured a steady place for Thrombolytic therapy in the management of heart attack. This has revolutionized the management of acute heart attack. There has to be a solid reason for withholding Thrombolytic therapy. Dewood studies showed that a clot is involved in hart attack in more than 85% of cases.

This aim is early, complete and sustained blood flow to heart muscle. Cloth dissolving strategy involving intracoronary and intravenous administration of various agents has eventually reached a state of consensus. Clot dissolving therapy to reperfuse reduces death rate by 21% in patients with heart attack that means saving 21 lives per 1000 patients. The effects are time dependent as evidence suggests maximal benefit within two hours, optimal within six hours though definite benefit lasts till 12 hours. An estimated 35 lives per 1000 are saved when initiated within one hour as against 16 lives per 1000 when given 7 – 12 hours after the onset of symptoms.

Who should get it?
Clot dissolving drugs benefit all patients irrespective of age, gender, and presences of other conditions like diabetes mellitus. All patient presenting with heart attack within six hours of onset of symptoms must be administered clot dissolving Thrombolytics. Patients presenting within 6-12 hours should be considered for Thrombolytics. Patients presenting with symptoms suggestive of heart attack with left bundle branch block an ECG finding, should be candidates for Thrombolysis. Patients presenting after 12 hours with persisting pain and ECG changes should be considered for reperfusion theraphy after weighing pros and cons. More aggressive approach is desirable in younger patients and those with large heart attacks. It is, however, the elderly who get more benefit from Thrombolytic therapy.
Concerted efforts should be made that maximum number of patients benefit from this therapy. Initial evaluation in casualty department and CCU should be prompt and should not take more than twenty minutes in total. Consolidated data shows that 1.6 lives can be saved per hour per 1000 patients. Time is muscle, and every effort should be made to administer Thrombolytics as soon as possible.

Precautions:
Patients with contraindications to clot dissolving thrombolytics, like active internal bleeding, history of stroke, brain tumour, suspected aortic dissection, prolonged resuscitation, proliferative retinopathy, acute pancreatitis, fixed accelerated high blood pressure and bleeding disorders should not be given Thrombolytics. Streptokinase should not be used after 7 days and before 6 months of first administration due to the presence of antibodies.

ANGIOPLASTY:
Rationale and Evidence:
Coronary angioplasty provides the distinct advantage of not only opening the occluded artery by taking care of the superimposed clot but also dilating the primary lesion. The success rate of opening the infarct related artery is 95%. With the employment of stents the results are getting better. Infarct related artery has to be opened quickly, with lower rates of acute and subacute occlusion and restenosis. A pioneer study showed higher patency rates of coronary artery with reduced morbidity and mortality rates. It can be employed as the first and only procedure called primary angioplasty. In case of failure of clot dissolving treatment it is used as a rescue procedure called rescue angioplasty. Primary angioplasty should be performed by skilled operators backed by experienced personnel.

Who should get it:
The evidence from different trials support better outcome in terms of morbidity and mortality with anagioplasty as compared to thrombolytics. This mode of reperfusion is preferable wherever the facilities and expertise are available. It is the treatment of choice for patients presenting with low blood pressure called cardiogenic shock associated with large infarcts. It is of great importance for patients who cannot receive clot dissolving thrombolytic therapy. Patients who have received thrombolytic therapy in the last six months or who are allergic to it can derive benefit from angioplasty. Patients who fail to respond to thrombolytic therapy should be subjected to angioplasty.

The time taken from reporting to hospital to inflation of balloon in patients undergoing angioplasty should be comparable to the time taken in patients receiving clot dissolving drugs. This requires prompt assessment and management in the casualty department and CCU. Quick and in time referral to the Catheterization laboratory is mandatory. Round the clock availability of skilled operators and experienced staff and a well stocked Catheterization laboratory are very essential for the success of any programme. Cardiac surgical team should be available in case of emergency.

Precautions:
This mode of reperfusion involves high cost due to high cost of catheterization laboratory and hardware involved. It is subject to the availability of highly skilled and experienced operator and staff round the clock. Very few hospitals have such facilities so this can be offered to a very small segment of society.

ASPIRIN:
Rationale and Evidence:
Very few treatment modalities have been so well and widely received and practiced as aspirin in heart attack. Aspirin in does of 40 mg can reduce the aggregation property of platelets. In a summary of 33 trials, heart attack in patients on Aspirin was reduced from 25% to 11%. Many trials have shown remarkable beneficial effect.

Who should get it?
Every patient with no contra-indication to aspirin should be given aspirin as soon as possible. Administration of beta blocker, ACE inhibitors, reperfusion with thrombolytic therapy or primary PTCA, presence of hypotension, hypertension, bundle branch block, complete heart block, diabetes pose no contraindication to aspirin.

Every patient with suspicion of heart attack should be given aspirin 300 mg to chew as soon as possible and continued indefinitely in dosage of 75 mg per day. Various enteric coded brands are available in the market to reduce hyperacidity.

Precautions:
Patients with proven ulcer on endoscopy or barium meal, history of gastic bleeding or those receiving antiulcer treatment should not be given aspirin. Patients with known allergy should not be given aspirin. Other platelet inhibitors may be considered in patients who have allergy or who cannot tolerate aspirin.
.
VESSEL DILATOR – NITRATE:
Rationale and Evidence:

Nitrates have muscle relaxation effect hence causing dilation of all vessels. This causes reduction in load on heart hence reducing oxygen demand. Intravenous therapy has been shown in animal and human models to reduce infarct size.

Who should get it?
Patients presenting, with heart attack in the first 24-48 hours, specially in large anterior heart attack, persistent chest pain and high blood pressure. It may be continued beyond 48 hours in patients with persistent chest pain or recurrent angina and breathlessness. Routine use after 24-48 hours is not recommended.

Nitroglycerine or Nitrate infusion is started and titrated while monitoring heart rate and blood pressure. Blood pressure reduction by 10% or heart rate increase by 10% should warrant reduction in dosage and closer monitoring. Long term oral therapy has not been found to have any significant effect on morbidity and mortality.

Precautions:
Patients presenting with blood pressure less than 90 mmHg, or slow heart rate should not be given Nitrate infusion. Lowering of blood pressure and increase in heart rate should be closely monitored.

BETA BLOCKERS:
Rationale and Evidence:
Beta blockers reduce heart rate and contractility hence decreasing oxygen demand. This has been shown to reduce heart attack size in animal and human models. Beta blockers decrease fatty acids. They have a well established role in ischaemia – reduce blood supply, arrhythmia – irregular heart beating and high blood pressure. Large trial and meta analysis have shown impressive reduction of morbidity and mortality with oral and intravenous beta blockers.

Who should get it?
Every patient regardless of age, gender, reperfusion strategy and therapy, time period, type of heart attack, associated comorbid condition should get it. It is of particular importance in patients with recurring chest pains, fast heart rate and high blood pressure.
Evolving heart attack should be given intravenous beta blocker watching blood pressure and heart rate closely. Oral therapy in appropriate dosage should be instituted at the earliest and continued preferably for two years. Perhaps all beta blockers in proper dosage confer similar effects. Beta blockers with longer half life have the advantage of convenience of dosage and lesser side effects.

Precautions:
Patients with asthma, chronic chest problems, low blood pressure – hypotension, overt heart failure, slow heart rate, uncontrolled or brittle diabetes should not be given beta blockers. Mild heart failure may be challenged with beta blockers under close supervision. Controlled diabetes is not a contraindication to beta blockers as the benefits outweigh the hazards.

ACE INHIBITORS:

Rationale and Evidence:
Dead – infracted segments stop contracting following a heart attack, other segments become hyperactive to maintain heart function. Heart undergoes remodeling in which it enlarges in size with increased wall tension on non infracted segments. Studies have shown that higher volumes are associated with higher chances of heart failure and increased morbidity and mortality. ACE inhibitors (ACEI) have been shown to reduce load on heart hence reducing wall tension and help is not increasing heart volumes. Use of ACE inhibitors in patients with symptoms of heart failure or evidence of reduced function derive maximal benefit with significant reduction of mortality and morbidity as shown in many large well conducted trials.

Who should get it?
All patients without contra indications to ACE inhibitors should be considered for it. It is particularly helpful in patients with symptoms and signs suggestive of heart failure or who have evidence of heart dysfunction – large dimensions and poor contraction even in absence of symptoms.

ACE inhibitors should be started with small dosage to obviate any low blood pressure episodes. The dose has to be built up gradually if patient can tolerate it. Systolic blood pressure should be mentioned closely. Optimal effects can only be expected at appropriate dosage Determined efforts should be made to optimize the dosage during hospitalization.

Precautions:
Patients with systolic blood pressure less than 90 mmHg should not be given ACEI. Those showing marked decrease in blood pressure, ACEI should be withheld and restarted at small dosage after some time. Those having persistent cough or intolerance to ACEI may be considered for Angiotensin receptor blockers like Losartan, Valsartan, Candesartan etc.

ANTI COAGUTANT – HEPARIN:
Rationale and Evidence:

Clot dissolving Drugs can open up the infarct related artery but for sustained patency Heparin had been advocated for a long time. Recent evidence from a large trial analysis does not support the regular use of Heparin following Streptokinase unless patient is at high risk for clot formation and dislodgement. Those patients who do not receive Thrombolytics may derive some benefit from Heparin. In the setting of unstable angina, intravenous Heparin has been shown to reduce morbidity and mortalilty.

Who should get it?
Patients presenting with unstable angina should get Heparin. Patients presenting late for thrombolytics should be considered for Heparin. In patients at high risk for clot formation and dislodgement like large or anterior infarction, irregular heart beat, or left ventricular clot, intravenous Heparin is preferred. Intravenous (IV) Heparin in patients receiving selective thrombolytics like tpa or alteplase is recommended.

Precaution:
Strick regimen should be followed as under dosage leads to treatment failure and overdosage causes bleeding complications.

FURTHER MANAGEMENT
This depends on the further course of disease. Uncomplicated heart attack patients are mobilized and discharged on 4th to 7th days of admission. An exit exercise tolerance test is favoured by some groups to identify patients at high risk requiring early angiography and intervention. Any mechanical, electrical or ischaemic complication is dealt with according to its merit.

_____________________________________________
Ref: Heal Thy Heart written by Prof: Dr. Muhammad Hafizullah


Read more...
 

Fitness | Copyright © 2009 |Fitness Tips | By Smart Fitness TV